Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer

Summary

Phase II trial to study the effectiveness of docetaxel in treating patients who have persistent or recurrent cervical cancer. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

Timeline

Start

2002-06

Primary completion

2006-10-23

Completion

—

Drugs

Indications